Inspiring Communication
Annually, more than 2.7M patients (40%) in US ICUs are unable to communicate, resulting in over $2.5B annual loss. Lack of communication leads to disorientation and higher rates of Delirium, a serious mental disturbance resulting in confused thinking and reduced awareness. Delirium affects 60-80% of intubated ICU patients; it is estimated to cost the US healthcare system $6B-20B annually. A patient’s ability to communicate results in more accurate medical care, decreased stress, and better patient outcomes. Although there have been advancements in assistive technology, the communication gap for patients, their families, and medical staff, remains unresolved; a holistic communication solution, contributing to digitally enabled care is required to improve the situation. EyeControl-Med is an innovative communication and monitoring solution for healthcare facilities that uses AI-powered eye-tracking technology to enable 24/7 bi-directional remote connectivity between patients who cannot speak, medical staff, and loved ones from afar. The product is a game-changer; it is the first solution of its kind for acute care settings. Invented to address unmet healthcare needs, the wearable device and smart platform connect people and bridge information barriers in ICUs, rehabilitation clinics, and long-term acute care centers. EyeControl–Home is a comprehensive communication solution for patients transitioning from medical facilities to remote home care and other Locked-in individuals, who cannot speak. It improves quality of life by providing round-the-clock connectivity and freedom of expression. It is the first wearable, screenless, assistive communication device without calibration or computer screen dependency.
Based on AI-powered eye-tracking technology, our wearable device and smart platforms enable 24/7 customizable communication and monitoring between patients who cannot speak, their families, and medical teams. The camera tracks pupil movements and transmits them to a small computer. Using adaptive, ML-based pattern recognition, eye gestures are analyzed and converted to real-time patient communication and actionable clinical data. EyeControl products also seamlessly integrate with clinical information platforms and other devices. EyeControl-Med is a communication solution for healthcare facilities, enabling remote connectivity between patients who cannot speak, medical teams, and loved ones. It aims to drive improved clinical outcomes via real-time analytics, and revolutionize the industry standard for medical communication. EyeControl-Med’s cutting-edge communication and monitoring features provide unique medical insight that enhances treatment accuracy, while increasing patient engagement and emotional wellbeing in intensive care units, long-term acute care facilities, and rehabilitation centers. By automating ubiquitous medical protocols known to increase patient orientation and connectedness, EyeControl-Med aims to improve detection and management of ICU Delirium and diminish hospital workload, leading to cost-savings and decreased length of stay. The products’ remote functionalities can improve medical team efficiency and reduce burnout, while ensuring safety in isolated wards. EyeControl–Home is a comprehensive communication solution for patients transitioning from medical facilities to remote home care and other Locked-in individuals, who cannot speak. It improves quality of life by providing round-the-clock connectivity and freedom of expression. Wearable and screenless, EyeControl-Med is available immediately upon waking, in transit, and outdoors, without screen dependency or calibration.
EyeControl is spearheading disruptive AI technologies, ensuring our unique role as industry pioneers. There are multiple alternative and augmentative communication (AAC) companies; their technologies are cumbersome, screen-dependent, and unavailable 24/7, leaving users devoid of communication. Competitors include: • Tobii Dynavox • LC Technologies (EyeGaze) • Prentke Romich (PRC) • Smartbox • Communication boards These AAC tools are not suited for the medical facility environment: 1. They require dedicated medical personnel at a patient’s bedside to hear and interpret communication 2. Their learning curves range from a few days to a week, while the average stay of ICU patients is 3.8 days. Additionally, our innovative technology offers a communication solution that continues to serve patients throughout their rehabilitation journey; from intensive care, to step-down units and long-term acute care, and to a home environment. EyeControl-Home is a game-changer for individuals with communication difficulties, offering solutions that previous devices haven’t achieved. As a wearable, screenless device, it provides a 24/7 communication solution, available immediately upon waking, in the bathroom, transit, and outdoors, without screen dependency or calibration. Our AI-technology makes EyeControl-Home the first assistive communication device that enables personalization based on the user’s precise range of eye motion, even at advanced stages of movement deterioration. EyeControl-Med is targeting an unserved market for ventilated facility patients, where we have confirmed high potential gain if we successfully introduce the product. We count on the strength of being the first company creating this new market, and the traction we are gaining enhances our leadership in this new blue ocean.
EyeControl has multiple use cases, where our communication solution delivered as promised by enhancing patient engagement and emotional wellbeing, leading to improved treatment accuracy and outcomes. Remote connectivity has also ensured safety and improved efficiency. One verified success story is that of patient M, a 50-year-old attorney from Jerusalem, who was admitted to an ICU COVID-19 ward for a month, ventilated, sedated and in a critical state. EyeControl-Med enabled remote communication between M and his family, who were relieved of the cumbersome, uncomfortable and alienating experience of being separated from their loved one during his time of isolation. They were comforted to understand through M’s use of EyeControl-Med, that he was indeed conscious and receptive to the messages they sent him via the device. EyeControl-Med also alleviated their fears of M not being able to call a nurse for help. Thanks to EyeControl-Med, M regained his sense of control as a ventilated COVID patient in the ICU, mentioning that “the most amazing thing about the device is waking up from anesthesia and actually being able to control something.” M went on to say that using EyeControl-Med gave him hope and motivation to get better. Additionally, M’s wife mentioned that “enabling family and friends to record and send messages through EyeControl-Med allowed them to feel involved in M’s recovery safely, which assisted him a lot.” M’s testimonial of the major positive impact that EyeControl-Med had on his recovery proves the device’s success in bridging ICU communication gaps and restoring patient motivation.
EyeControl’s digital health products empower patients who cannot communicate to take control of their wellness; creating a standard of care for communication with medical staff improves treatment accuracy and outcomes. With the potential to detect and manage Delirium, EyeControl-Med is expected to decrease hospital costs and length of stay.
